Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Personal meaning of work and perceived work ability among middle-aged workers with physically strenuous work: a Northern Finland Birth Cohort 1966 Study.

Punakallio A, Lusa S, Ala-Mursula L, Ek E, Nevanperä N, Remes J, Auvinen J, Seitsamo J, Karppinen J, Laitinen J.

Int Arch Occup Environ Health. 2019 Apr;92(3):371-381. doi: 10.1007/s00420-019-01412-9. Epub 2019 Feb 14.

2.

Interventions to enhance recovery in healthy workers; a scoping review.

Verbeek J, Ruotsalainen J, Laitinen J, Korkiakangas E, Lusa S, Mänttäri S, Oksanen T.

Occup Med (Lond). 2019 Feb 7;69(1):54-63. doi: 10.1093/occmed/kqy141.

PMID:
30380126
3.

Structural Characterization of Self-Assembling Hybrid Nanoparticles for Bisphosphonate Delivery in Tumors.

Ristori S, Grillo I, Lusa S, Thamm J, Valentino G, Campani V, Caraglia M, Steiniger F, Luciani P, De Rosa G.

Mol Pharm. 2018 Mar 5;15(3):1258-1265. doi: 10.1021/acs.molpharmaceut.7b01085. Epub 2018 Feb 20.

PMID:
29433321
4.

A practical guidance for assessments of sedentary behavior at work: A PEROSH initiative.

Holtermann A, Schellewald V, Mathiassen SE, Gupta N, Pinder A, Punakallio A, Veiersted KB, Weber B, Takala EP, Draicchio F, Enquist H, Desbrosses K, García Sanz MP, Malińska M, Villar M, Wichtl M, Strebl M, Forsman M, Lusa S, Tokarski T, Hendriksen P, Ellegast R.

Appl Ergon. 2017 Sep;63:41-52. doi: 10.1016/j.apergo.2017.03.012. Epub 2017 Apr 11.

5.

Moving to business - changes in physical activity and sedentary behavior after multilevel intervention in small and medium-size workplaces.

Aittasalo M, Livson M, Lusa S, Romo A, Vähä-Ypyä H, Tokola K, Sievänen H, Mänttäri A, Vasankari T.

BMC Public Health. 2017 Apr 17;17(1):319. doi: 10.1186/s12889-017-4229-4.

6.

Physiological Load and Psychological Stress During a 24-hour Work Shift Among Finnish Firefighters.

Kaikkonen P, Lindholm H, Lusa S.

J Occup Environ Med. 2017 Jan;59(1):41-46. doi: 10.1097/JOM.0000000000000912.

PMID:
28045796
7.

Neuromuscular exercise and back counselling for female nursing personnel with recurrent non-specific low back pain: study protocol of a randomised controlled trial (NURSE-RCT).

Suni JH, Rinne M, Kankaanpää M, Taulaniemi A, Lusa S, Lindholm H, Parkkari J.

BMJ Open Sport Exerc Med. 2016 Mar 3;2(1):e000098. eCollection 2016.

8.

A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR.

Tosco A, De Gregorio F, Esposito S, De Stefano D, Sana I, Ferrari E, Sepe A, Salvadori L, Buonpensiero P, Di Pasqua A, Grassia R, Leone CA, Guido S, De Rosa G, Lusa S, Bona G, Stoll G, Maiuri MC, Mehta A, Kroemer G, Maiuri L, Raia V.

Cell Death Differ. 2017 Jul;24(7):1305. doi: 10.1038/cdd.2016.43. Epub 2016 Jul 22.

9.

Transferrin-Targeted Nanoparticles Containing Zoledronic Acid as a Potential Tool to Inhibit Glioblastoma Growth.

Salzano G, Zappavigna S, Luce A, D'Onofrio N, Balestrieri ML, Grimaldi A, Lusa S, Ingrosso D, Artuso S, Porru M, Leonetti C, Caraglia M, De Rosa G.

J Biomed Nanotechnol. 2016 Apr;12(4):811-30.

PMID:
27301207
10.

A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR.

Tosco A, De Gregorio F, Esposito S, De Stefano D, Sana I, Ferrari E, Sepe A, Salvadori L, Buonpensiero P, Di Pasqua A, Grassia R, Leone CA, Guido S, De Rosa G, Lusa S, Bona G, Stoll G, Maiuri MC, Mehta A, Kroemer G, Maiuri L, Raia V.

Cell Death Differ. 2016 Aug;23(8):1380-93. doi: 10.1038/cdd.2016.22. Epub 2016 Apr 1. Erratum in: Cell Death Differ. 2017 Jul;24(7):1305.

11.

CXCR4-antagonist Peptide R-liposomes for combined therapy against lung metastasis.

Ieranò C, Portella L, Lusa S, Salzano G, D'Alterio C, Napolitano M, Buoncervello M, Macchia D, Spada M, Barbieri A, Luciano A, Barone MV, Gabriele L, Caraglia M, Arra C, De Rosa G, Scala S.

Nanoscale. 2016 Apr 14;8(14):7562-71. doi: 10.1039/c5nr06335c.

PMID:
26983756
12.

Zoledronic acid-encapsulating self-assembling nanoparticles and doxorubicin: a combinatorial approach to overcome simultaneously chemoresistance and immunoresistance in breast tumors.

Kopecka J, Porto S, Lusa S, Gazzano E, Salzano G, Pinzòn-Daza ML, Giordano A, Desiderio V, Ghigo D, De Rosa G, Caraglia M, Riganti C.

Oncotarget. 2016 Apr 12;7(15):20753-72. doi: 10.18632/oncotarget.8012.

13.

Lipid Nanovectors to Deliver RNA Oligonucleotides in Cancer.

Campani V, Salzano G, Lusa S, De Rosa G.

Nanomaterials (Basel). 2016 Jul 9;6(7). pii: E131. doi: 10.3390/nano6070131. Review.

14.

Self-assembling nanoparticles encapsulating zoledronic acid revert multidrug resistance in cancer cells.

Kopecka J, Porto S, Lusa S, Gazzano E, Salzano G, Giordano A, Desiderio V, Ghigo D, Caraglia M, De Rosa G, Riganti C.

Oncotarget. 2015 Oct 13;6(31):31461-78. doi: 10.18632/oncotarget.5058.

15.

Nanoparticles for the delivery of zoledronic acid to prostate cancer cells: a comparative analysis through time lapse video-microscopy technique.

Schiraldi C, Zappavigna S, D' Agostino A, Porto S, Gaito O, Lusa S, Lamberti M, De Rosa M, De Rosa G, Caraglia M.

Cancer Biol Ther. 2014;15(11):1524-32. doi: 10.4161/15384047.2014.955989.

16.

Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acid.

Porru M, Zappavigna S, Salzano G, Luce A, Stoppacciaro A, Balestrieri ML, Artuso S, Lusa S, De Rosa G, Leonetti C, Caraglia M.

Oncotarget. 2014 Nov 15;5(21):10446-59.

17.

Developmental trajectories of multisite musculoskeletal pain and depressive symptoms: the effects of job demands and resources and individual factors.

Airila A, Hakanen JJ, Luukkonen R, Lusa S, Punakallio A, Leino-Arjas P.

Psychol Health. 2014;29(12):1421-41. doi: 10.1080/08870446.2014.945929. Epub 2014 Aug 14.

PMID:
25096992
18.

Sleep disturbances predict long-term changes in low back pain among Finnish firefighters: 13-year follow-up study.

Lusa S, Miranda H, Luukkonen R, Punakallio A.

Int Arch Occup Environ Health. 2015 Apr;88(3):369-79. doi: 10.1007/s00420-014-0968-z. Epub 2014 Aug 2.

19.

Musculoskeletal pain and depressive symptoms as predictors of trajectories in work ability among finnish firefighters at 13-year follow-up.

Punakallio A, Lusa S, Luukkonen R, Airila A, Leino-Arjas P.

J Occup Environ Med. 2014 Apr;56(4):367-75. doi: 10.1097/JOM.0000000000000139.

PMID:
24709762
20.

In vivo activity of miR-34a mimics delivered by stable nucleic acid lipid particles (SNALPs) against multiple myeloma.

Di Martino MT, Campani V, Misso G, Gallo Cantafio ME, Gullà A, Foresta U, Guzzi PH, Castellano M, Grimaldi A, Gigantino V, Franco R, Lusa S, Cannataro M, Tagliaferri P, De Rosa G, Tassone P, Caraglia M.

PLoS One. 2014 Feb 27;9(2):e90005. doi: 10.1371/journal.pone.0090005. eCollection 2014.

21.

Insights in the chemical components of liposomes responsible for P-glycoprotein inhibition.

Kopecka J, Salzano G, Campia I, Lusa S, Ghigo D, De Rosa G, Riganti C.

Nanomedicine. 2014 Jan;10(1):77-87. doi: 10.1016/j.nano.2013.06.013. Epub 2013 Jul 10.

22.

Positive and negative mood trajectories and their relationship with work ability, self-rated health, and life satisfaction: a 13-year follow-up study.

Airila A, Hakanen JJ, Luukkonen R, Lusa S, Punakallio A.

J Occup Environ Med. 2013 Jul;55(7):779-85. doi: 10.1097/JOM.0b013e3182988925.

PMID:
23787567
23.

Firefighters muscular recovery after a heavy work bout in the heat.

Oksa J, Rintamäki H, Takatalo K, Mäkinen T, Lusa S, Lindholm H, Rissanen S.

Appl Physiol Nutr Metab. 2013 Mar;38(3):292-9. doi: 10.1139/apnm-2012-0180. Epub 2012 Oct 17.

PMID:
23537021
24.

Stealth liposomes encapsulating zoledronic acid: a new opportunity to treat neuropathic pain.

Caraglia M, Luongo L, Salzano G, Zappavigna S, Marra M, Guida F, Lusa S, Giordano C, De Novellis V, Rossi F, Abbruzzese Saccardi A, De Rosa G, Maione S.

Mol Pharm. 2013 Mar 4;10(3):1111-8. doi: 10.1021/mp3006215. Epub 2013 Feb 14.

PMID:
23327778
25.

Lifestyle factors predicting changes in aerobic capacity of aging firefighters at 3- and 13-year follow-ups.

Punakallio A, Lindholm H, Luukkonen R, Lusa S.

J Occup Environ Med. 2012 Sep;54(9):1133-41. doi: 10.1097/JOM.0b013e3182554b11.

PMID:
22892548
26.

Is work engagement related to work ability beyond working conditions and lifestyle factors?

Airila A, Hakanen J, Punakallio A, Lusa S, Luukkonen R.

Int Arch Occup Environ Health. 2012 Nov;85(8):915-25. doi: 10.1007/s00420-012-0732-1. Epub 2012 Jan 21.

PMID:
22270385
27.

Association of cardio-ankle vascular index with physical fitness and cognitive symptoms in aging Finnish firefighters.

Lindholm H, Punakallio A, Lusa S, Sainio M, Ponocny E, Winker R.

Int Arch Occup Environ Health. 2012 May;85(4):397-403. doi: 10.1007/s00420-011-0681-0. Epub 2011 Jul 26.

PMID:
21789686
28.

[Respiratory tract symptoms and illnesses in rescue and clearance workers after the World Trade Center catastrophe].

Aro L, Sauni R, Lusa S, Lindholm H, Uitti J.

Duodecim. 2009;125(16):1709-16. Finnish.

PMID:
19839191
29.

Factors associated with changes in perceived strain at work among fire-fighters: a 3-year follow-up study.

Lusa S, Punakallio A, Luukkonen R, Louhevaara V.

Int Arch Occup Environ Health. 2006 May;79(5):419-26. Epub 2005 Dec 6.

PMID:
16331518
30.

Overexpression of OSBP-related protein 2 (ORP2) induces changes in cellular cholesterol metabolism and enhances endocytosis.

Hynynen R, Laitinen S, Käkelä R, Tanhuanpää K, Lusa S, Ehnholm C, Somerharju P, Ikonen E, Olkkonen VM.

Biochem J. 2005 Aug 15;390(Pt 1):273-83.

31.

Functional, postural and perceived balance for predicting the work ability of firefighters.

Punakallio A, Lusa S, Luukkonen R.

Int Arch Occup Environ Health. 2004 Oct;77(7):482-90. Epub 2004 Sep 2.

PMID:
15558300
32.

Secretion of sterols and the NPC2 protein from primary astrocytes.

Mutka AL, Lusa S, Linder MD, Jokitalo E, Kopra O, Jauhiainen M, Ikonen E.

J Biol Chem. 2004 Nov 19;279(47):48654-62. Epub 2004 Sep 7.

33.

Caveolins and membrane cholesterol.

Ikonen E, Heino S, Lusa S.

Biochem Soc Trans. 2004 Feb;32(Pt 1):121-3. Review.

PMID:
14748728
34.

Protective equipment affects balance abilities differently in younger and older firefighters.

Punaxallio A, Lusa S, Luukkonen R.

Aviat Space Environ Med. 2003 Nov;74(11):1151-6.

PMID:
14620471
35.

Differential mobilization of newly synthesized cholesterol and biosynthetic sterol precursors from cells.

Lusa S, Heino S, Ikonen E.

J Biol Chem. 2003 May 30;278(22):19844-51. Epub 2003 Mar 25.

36.

Depletion of rafts in late endocytic membranes is controlled by NPC1-dependent recycling of cholesterol to the plasma membrane.

Lusa S, Blom TS, Eskelinen EL, Kuismanen E, Månsson JE, Simons K, Ikonen E.

J Cell Sci. 2001 May;114(Pt 10):1893-900.

37.

Dissecting the role of the golgi complex and lipid rafts in biosynthetic transport of cholesterol to the cell surface.

Heino S, Lusa S, Somerharju P, Ehnholm C, Olkkonen VM, Ikonen E.

Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8375-80.

38.

Direct observation of lipoprotein cholesterol ester degradation in lysosomes.

Lusa S, Tanhuanpää K, Ezra T, Somerharju P.

Biochem J. 1998 Jun 1;332 ( Pt 2):451-7.

40.

Human arterial proteoglycans increase the rate of proteolytic fusion of low density lipoprotein particles.

Pentikäinen MO, Lehtonen EM, Oörni K, Lusa S, Somerharju P, Jauhiainen M, Kovanen PT.

J Biol Chem. 1997 Oct 3;272(40):25283-8.

42.
43.

Are the job demands on physical work capacity equal for young and aging firefighters?

Lusa S, Louhevaara V, Kinnunen K.

J Occup Med. 1994 Jan;36(1):70-4.

PMID:
8138852
44.

Physiological responses of firefighting students during simulated smoke-diving in the heat.

Lusa S, Louhevaara V, Smolander J, Kivimäki M, Korhonen O.

Am Ind Hyg Assoc J. 1993 May;54(5):228-31.

PMID:
8498358
45.

The effect of appraisers in estimating metabolic rate with the Edholm scale.

Kähkönen E, Nykyri E, Ilmarinen R, Ketola R, Lusa S, Nygård CH, Suurnäkki T.

Appl Ergon. 1992 Jun;23(3):186-90.

PMID:
15676866
46.

Elongation of both branches of biantennary backbones of oligo-(N-acetyllactosamino)glycans by human serum (1----3)-N-acetyl-beta-D- glucosaminyltransferase.

Vilkman A, Niemelä R, Penttilä L, Helin J, Leppänen A, Seppo A, Maaheimo H, Lusa S, Renkonen O.

Carbohydr Res. 1992 Mar 16;226(1):155-74.

PMID:
1386788
47.

Fate of the 6K membrane protein of Semliki Forest virus during virus assembly.

Lusa S, Garoff H, Liljeström P.

Virology. 1991 Dec;185(2):843-6.

PMID:
1962454
48.

Biomechanical evaluation of heavy tool-handling in two age groups of firemen.

Lusa S, Louhevaara V, Smolander J, Kinnunen K, Korhonen O, Soukainen J.

Ergonomics. 1991 Dec;34(12):1429-32.

PMID:
1800108
49.

Human serum contains a novel beta 1,6-N-acetylglucosaminyltransferase activity that is involved in midchain branching of oligo (N-acetyllactosaminoglycans).

Leppänen A, Penttilä L, Niemelä R, Helin J, Seppo A, Lusa S, Renkonen O.

Biochemistry. 1991 Sep 24;30(38):9287-96.

PMID:
1832557

Supplemental Content

Support Center